ABT-493
Showing 1 - 25 of 384
Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)
Completed
- Chronic Hepatitis C Virus (HCV) Infection
- ABT-493/ABT-530
- Placebo for ABT-493/ABT-530
- (no location specified)
Jul 14, 2021
Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Jul 9, 2021
Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))
Completed
- Chronic Hepatitis C
- Hepatitis C Virus
- ABT-493
- +3 more
- (no location specified)
Jul 9, 2021
Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))
Completed
- Chronic Hepatitis C Virus
- Hepatitis C Virus
- ABT-493/ABT-530
- +2 more
- (no location specified)
Jul 14, 2021
Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)
Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, OBV/PTV/r)
Completed
- Chronic Hepatitis C Virus
- Hepatitis C Virus
- (no location specified)
Jul 14, 2021
Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)
Completed
- Hepatitis C Virus Infection
- +2 more
- (no location specified)
Jul 9, 2021
Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with
Completed
- Hepatitis C Virus Infection
- +3 more
- ABT-493 coformulated with ABT-530
- (no location specified)
Jul 9, 2021
Chronic Hepatitis C, HCV, Hepatitis C Virus Trial (glecaprevir/pibrentasvir)
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Jul 9, 2021
Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333)
Completed
- Chronic Hepatitis C
- +2 more
- ABT-493
- +3 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)
Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric
Completed
- Hepatitis C Virus (HCV)
- Glecaprevir/pibrentasvir adult formulation
- Glecaprevir/pibrentasvir pediatric formulation
-
San Francisco, California
- +37 more
Sep 19, 2022
Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)
Completed
- Hepatitis C Virus (HCV)
-
San Diego, California
- +24 more
Jul 14, 2021
Hepatitis C Virus Infection Trial in Ljubljana (glecaprevir, pibrentasvir)
Approved for marketing
- Hepatitis C Virus Infection
-
Ljubljana, SloveniaUniv Medical Ctr Ljubljana /ID# 161419
Jan 14, 2020
Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir (GLE/PIB))
Recruiting
- Hepatitis C Virus (HCV)
- Glecaprevir/Pibrentasvir (GLE/PIB)
-
Chandler, Arizona
- +62 more
Aug 8, 2022
Hepatitis C Virus (HCV) Trial in China, Korea, Republic of (Glecaprevir/Pibrentasvir)
Completed
- Hepatitis C Virus (HCV)
-
Beijing, Beijing, China
- +33 more
Nov 4, 2019
Hepatitis C Virus (HCV) Trial in China, Korea, Republic of, Singapore (Placebo, Glecaprevir/Pibrentasvir)
Completed
- Hepatitis C Virus (HCV)
- Placebo
- Glecaprevir/Pibrentasvir
-
Beijing, Beijing, China
- +47 more
Dec 5, 2019
Relapsed Refractory Multiple Myeloma Trial in United States (Abemaciclib, dexamethasone, ixazomib, pomalidomide, Enasidenib,
Recruiting
- Relapsed Refractory Multiple Myeloma
- Abemaciclib, dexamethasone, ixazomib, pomalidomide
- +7 more
-
Phoenix, Arizona
- +16 more
Sep 9, 2021
Hepatitis C Virus (HCV) Trial in Brazil (Glecaprevir/Pibrentasvir)
Completed
- Hepatitis C Virus (HCV)
-
Vitoria, Espirito Santo, Brazil
- +13 more
Mar 4, 2020
Insomnia, Traumatic Brain Injury Trial in Palo Alto (CBT-I, ABT-I)
Recruiting
- Insomnia
- Traumatic Brain Injury
- CBT-I
- ABT-I
-
Palo Alto, CaliforniaVA Palo Alto Health Care System, Palo Alto, CA
Jan 6, 2023
Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Pneumococcal 13-valent conjugate vaccine (PCV-13))
Completed
- Rheumatoid Arthritis
- Upadacitinib
- Pneumococcal 13-valent conjugate vaccine (PCV-13)
-
Huntsville, Alabama
- +123 more
Jun 15, 2022
Aveir DR Real-World Evidence Post-Approval Study
Not yet recruiting
- Cardiac Pacemaker
- +2 more
- Aveir DR Leadless Pacemaker System
-
Sylmar, CaliforniaAbbott
Jul 5, 2023
Aveir AR Coverage With Evidence Development (CED) Study
Not yet recruiting
- Cardiac Pacemaker
- +2 more
- Aveir AR Leadless Pacemaker
- Single-chamber atrial transvenous pacemaker
- (no location specified)
Oct 30, 2023